Order Article Reprints

Razazi K, Gendreau S, Cuquemelle E, Khellaf M, Guillaud C, Godeau B, Melica G, Moutereau S, Gomart C, Fourati S, et al. Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease. Journal of Clinical Medicine. 2020; 9(11):3718. https://doi.org/10.3390/jcm9113718

Razazi, Keyvan, Ségolène Gendreau, Elise Cuquemelle, Mehdi Khellaf, Constance Guillaud, Bertrand Godeau, Giovanna Melica, Stéphane Moutereau, Camille Gomart, Slim Fourati, and et al. 2020. "Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease" Journal of Clinical Medicine 9, no. 11: 3718. https://doi.org/10.3390/jcm9113718

Razazi, K., Gendreau, S., Cuquemelle, E., Khellaf, M., Guillaud, C., Godeau, B., Melica, G., Moutereau, S., Gomart, C., Fourati, S., De Prost, N., Carteaux, G., Brun-Buisson, C., Bartolucci, P., Habibi, A., & Mekontso Dessap, A. (2020). Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease. Journal of Clinical Medicine, 9(11), 3718. https://doi.org/10.3390/jcm9113718